• Publications
  • Influence
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology
Developed in Collaboration With the American Association forThoracic Surgery and Society of Thoracic Surgeons, this work aims to provide real-time information about the safe and effective use of ultrasound for diagnosis and treatment of central giant cell granuloma. Expand
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
Ventricular desynchronization imposed by ventricular pacing even when AV synchrony is preserved increases the risk of HF hospitalization and AF in SND with normal baseline QRSd. Expand
ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines
2008;51;2085-2105; originally published online May 15, 2008; J. Am. Coll. Cardiol. Michael O. Sweeney L. Page, Mark H. Schoenfeld, Michael J. Silka, Lynne Warner Stevenson, and Stephen C. Hammill,Expand
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction.
Overall, dual-chamber pacing offers significant improvement as compared with ventricular pacing, and reduces the risk of atrial fibrillation, reduces signs and symptoms of heart failure, and slightly improves the quality of life. Expand
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.
The American College of Cardiology Foundation Board of Trustees in February 2008, document be cited as follows. Expand
Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease.
Dual-chamber minimal ventricular pacing, as compared with conventional dual- chamber pacing, prevents ventricular desynchronization and moderately reduces the risk of persistent atrial fibrillation in patients with sinus-node disease. Expand
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Sidney C. Smith, Jr, MD, FACC, FAHA, Chair Alice K. Jacobs, MD, FACC, FAHA, Vice-Chair Cynthia D. Adams, RN, PhD, FAHA[§][1] Jeffrey L. Anderson, MD, FACC, FAHA[§][1] Christopher E. Buller, MD,Expand
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)
AHRE detected by pacemakers in patients with SND identify patients that are more than twice as likely to die or have a stroke, and 6 times as likelyto develop atrial fibrillation as similar patients without AHRE. Expand
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
Among survivors of ventricular fibrillation or sustained ventricular tachycardia causing severe symptoms, the implantable cardioverter-defibrillator is superior to antiarrhythmic drugs for increasing overall survival. Expand